![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paul Tan, Cindy Lee, Lutz Beckert
Case reportA 95-year-old man presented initially with a right toe pain
secondary to osteomyelitis and was treated in hospital with intravenous
antibiotics. He developed dyspnoea whilst in hospital and a chest X-ray revealed
a large right-sided pneumothorax for which he underwent a fluoroscopic insertion
of a right pleurocath. He had ongoing symptoms following the pleurocath
insertion and clinical assessment revealed a non-functioning tube.
A CT chest showed a malpositioned pleurocath, outside the
pleural space positioned underneath the right pectoral muscle, emphysematous
changes including a large right lower lobe bullae and a persistent large right
pneumothorax,
A 12 Fr Rocket drain was inserted. The patient made some
symptomatic improvements however the lung did not inflate fully. Because of the
ongoing air leak a larger a 24 Fr drain was inserted as per the BTS
guidelines.1 Despite these changes the patient
had ongoing air leak and radiological unresolved pneumothorax.
On day 16 he underwent a pleurodesis with 100 ml of FFP
which was instilled into his pleura via his intercostal drain. His air leak
stopped within a few hours and his pneumothorax resolved both clinically and
radiologically. His intercostal drain was removed on day 18, he was discharged
from hospital and has not had a relapse of his pneumothorax.
DiscussionThis case highlights three management aspects:
The current BTS guidelines suggest consideration
of chemical pleurodesis if the patient is unwilling or unable to undergo
surgery. The chemical agents generally used are talc or
doxycycline.1 Given the problems sourcing
intrapleural doxycycline and the reported adverse effects of talc, we decided on
FFP as a biological glue for this patient.2
Fibrin is considered a biological glue, the substrate of
which can come from plasma in the form of cryoprecipitate or fresh frozen
plasma. Two small studies have shown promising outcomes of resolution and
reduced recurrence of pneumothoraces in the use of biological glue in patients
with persisting air leaks. Methods of instillations include directly into the
pleural space via the intercostals drain or selective intrabronchial
tamponade.3
Author information: Paul Tan, Advanced
Trainee Respiratory Medicine; Cindy Lee, Respiratory Physician; Lutz Beckert,
Respiratory Physician; Department of Respiratory Medicine, Christchurch
Hospital, Christchurch
Correspondence: Lutz Beckert, Department of
Respiratory Medicine, Christchurch Hospital, Christchurch 8011, New Zealand.
Fax: +64 (0)3 3640914; email: Lutz.Beckert@cdhb.health.nz
References:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |